BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8625964)

  • 1. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
    Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
    Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood- and skin-derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin-sensitive signal transduction pathway.
    Zwirner J; Götze O; Moser A; Sieber A; Begemann G; Kapp A; Elsner J; Werfel T
    Eur J Immunol; 1997 Sep; 27(9):2317-22. PubMed ID: 9341775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells.
    Xie P; Nishiura H; Semba U; Chen J; Zhao R; Kuniyasu A; Yamamoto T
    Int Immunopharmacol; 2012 Jan; 12(1):158-68. PubMed ID: 22155625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors.
    Bischoff SC; Krieger M; Brunner T; Rot A; von Tscharner V; Baggiolini M; Dahinden CA
    Eur J Immunol; 1993 Mar; 23(3):761-7. PubMed ID: 7680615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.
    Ali H; Ahamed J; Hernandez-Munain C; Baron JL; Krangel MS; Patel DD
    J Immunol; 2000 Dec; 165(12):7215-23. PubMed ID: 11120854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human phagocytic cell receptors for C5A and platelet activating factor expressed in Xenopus oocytes.
    Murphy PM; Gallin EK; Tiffany HL
    J Immunol; 1990 Oct; 145(7):2227-34. PubMed ID: 2168918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3a and C5a stimulate chemotaxis of human mast cells.
    Hartmann K; Henz BM; Krüger-Krasagakes S; Köhl J; Burger R; Guhl S; Haase I; Lippert U; Zuberbier T
    Blood; 1997 Apr; 89(8):2863-70. PubMed ID: 9108406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.
    Gerardy-Schahn R; Ambrosius D; Saunders D; Casaretto M; Mittler C; Karwarth G; Görgen S; Bitter-Suermann D
    Eur J Immunol; 1989 Jun; 19(6):1095-102. PubMed ID: 2666143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.
    Venkatesha RT; Berla Thangam E; Zaidi AK; Ali H
    Mol Immunol; 2005 Mar; 42(5):581-7. PubMed ID: 15607817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
    Mousli M; Hugli TE; Landry Y; Bronner C
    J Immunol; 1992 Apr; 148(8):2456-61. PubMed ID: 1373170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
    Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of intercellular adhesion molecule 1 (ICAM-1) expression on the human mast-cell line (HMC)-1 by inflammatory mediators.
    Wedi B; Elsner J; Czech W; Butterfield JH; Kapp A
    Allergy; 1996 Oct; 51(10):676-84. PubMed ID: 8904994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
    J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
    Füreder W; Agis H; Willheim M; Bankl HC; Maier U; Kishi K; Müller MR; Czerwenka K; Radaszkiewicz T; Butterfield JH; Klappacher GW; Sperr WR; Oppermann M; Lechner K; Valent P
    J Immunol; 1995 Sep; 155(6):3152-60. PubMed ID: 7673728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.